Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Macular dystrophy that is related to a change in a gene.
Biomarker and diagnostic research for hereditary macular dystrophy has been reported in the published literature.
2 clinical trials registered, 1 recruiting. Interventions under study include other interventions and medical devices. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
171 publications have been identified in PubMed for hereditary macular dystrophy. Research spans Basic Science / Preclinical (39%), Review / Meta-Analysis (25%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 66 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 7:54 AM UTC
European rare disease database
Research summaries | 43 | 25% |
Disease patterns and progression | 27 | 16% |
New treatment approaches | 18 | 11% |
Patient case studies | 8 | 5% |
Clinical study results | 5 | 3% |
Testing and diagnosis research | 3 | 2% |
Other research | 1 | 1% |
Wang AG (2026). [PMID: 41534124](https://pubmed.ncbi.nlm.nih.gov/41534124/). *Stem cell research*. [Basic Science / Preclinical]
Tatemoto Y (2026). [PMID: 41051727](https://pubmed.ncbi.nlm.nih.gov/41051727/). *Doc Ophthalmol*. [Case Report / Case Series]
Alibrandi S (2026). [PMID: 42123608](https://pubmed.ncbi.nlm.nih.gov/42123608/). *Int J Mol Sci*. [Other]
Chen S (2026). [PMID: 41524889](https://pubmed.ncbi.nlm.nih.gov/41524889/). *Eur J Epidemiol*. [Epidemiology / Natural History]
Nanji K (2026). [PMID: 40803536](https://pubmed.ncbi.nlm.nih.gov/40803536/). *Ophthalmology*. [Review / Meta-Analysis]
Amaxilati E (2026). [PMID: 41744818](https://pubmed.ncbi.nlm.nih.gov/41744818/). *Cells*. [Review / Meta-Analysis]
Chen KY (2026). [PMID: 41935442](https://pubmed.ncbi.nlm.nih.gov/41935442/). *Redox Biol*. [Review / Meta-Analysis]
Laich Y (2026). [PMID: 42217979](https://pubmed.ncbi.nlm.nih.gov/42217979/). *Handb Clin Neurol*. [Review / Meta-Analysis]
Wang SK (2026). [PMID: 41528844](https://pubmed.ncbi.nlm.nih.gov/41528844/). *Cell Rep*. [Basic Science / Preclinical]
Yang Z (2026). [PMID: 41232598](https://pubmed.ncbi.nlm.nih.gov/41232598/). *Prog Retin Eye Res*. [Review / Meta-Analysis]